BE900125A - Compositions pharmaceutiques synergiques. - Google Patents
Compositions pharmaceutiques synergiques. Download PDFInfo
- Publication number
- BE900125A BE900125A BE213306A BE213306A BE900125A BE 900125 A BE900125 A BE 900125A BE 213306 A BE213306 A BE 213306A BE 213306 A BE213306 A BE 213306A BE 900125 A BE900125 A BE 900125A
- Authority
- BE
- Belgium
- Prior art keywords
- pharmaceutical compositions
- synergistic pharmaceutical
- liver
- phosphate
- treatment
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Compositions pharmaceutiques synergiques pour le traitement des troubles du foie comportant un ortho-phosphate de 5-aminoimidazole-4-carboxamide (phosphate AICA) à titre d'ingrédient actif et en association avec une ou plusieurs vitamines, de préférence la vitamine B et/ou la vitamine E, facultativement avec un ou plusieurs autres excépients pharmaceutiques. La composition est adéquate au traitement de la stéatose hépatique et autres affections du foie y compris les cirrhoses et les hépatites.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU832463A HU190597B (en) | 1983-07-11 | 1983-07-11 | Process for preparing synrtgetic pharmaceutical compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
BE900125A true BE900125A (fr) | 1984-11-05 |
Family
ID=10959498
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BE213306A BE900125A (fr) | 1983-07-11 | 1984-07-10 | Compositions pharmaceutiques synergiques. |
Country Status (11)
Country | Link |
---|---|
US (1) | US4581348A (fr) |
AT (1) | AT389052B (fr) |
BE (1) | BE900125A (fr) |
CA (1) | CA1238576A (fr) |
CH (1) | CH661866A5 (fr) |
DE (1) | DE3425466A1 (fr) |
FR (1) | FR2548900B1 (fr) |
GB (1) | GB2144417B (fr) |
HU (1) | HU190597B (fr) |
IT (1) | IT1214843B (fr) |
SE (1) | SE464683B (fr) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4204097A (en) * | 1977-02-25 | 1980-05-20 | Schmit John W | Lockable covering apparatus for telephone dials |
US4396810A (en) * | 1979-12-03 | 1983-08-02 | Cover Hunter H | Pushbutton telephone dial locks |
DE3711640A1 (de) * | 1987-04-07 | 1988-10-27 | Hollingsworth Gmbh | Vorrichtung zum reinigen und oeffnen von textil-fasergut |
US5622991A (en) * | 1994-08-30 | 1997-04-22 | Cornell Research Foundation, Inc. | Treating inflammatory liver disorders by enterally administering a fat-containing diet low in polyunsaturated fats |
US5728707A (en) * | 1995-07-21 | 1998-03-17 | Constantia Gruppe | Treatment and prevention of primary and metastatic neoplasms with salts of aminoimidazole carboxamide |
JP4422796B2 (ja) * | 1995-07-21 | 2010-02-24 | タクティカル セラピューティクス インコーポレイテッド | アミノイミダゾールカルボキサミドおよび5−アミノ、または置換アミノ1,2,3−トリアゾールの塩による癌の治療および阻止 |
US6184227B1 (en) * | 1995-07-21 | 2001-02-06 | Savvipharm Inc. | Salts of aminoimidazole carboxamide useful in the prevention and treatment of liver diseases |
US20050220862A1 (en) * | 2004-03-31 | 2005-10-06 | Bernstein Joel E | Compositions with reduced hepatotoxicity |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1210865B (de) * | 1962-03-05 | 1966-02-17 | Fujisawa Pharmaceutical Co | Verfahren zur Herstellung des 2, 6-dioxo-tetrahydropyrimidin-4-carbonsauren Salzes des 4-Amino-5-imidazolcarbonsaeureamids |
US4182770A (en) * | 1976-10-09 | 1980-01-08 | Merck Patent Gesellschaft Mit Beschraenkter Haftung | Alcohol deterrent |
JPS58126767A (ja) * | 1982-01-22 | 1983-07-28 | Ajinomoto Co Inc | 肝臓病患者用栄養組成物 |
-
1983
- 1983-07-11 HU HU832463A patent/HU190597B/hu not_active IP Right Cessation
-
1984
- 1984-07-04 IT IT8467682A patent/IT1214843B/it active
- 1984-07-09 FR FR8410863A patent/FR2548900B1/fr not_active Expired
- 1984-07-09 AT AT0220684A patent/AT389052B/de not_active IP Right Cessation
- 1984-07-10 CH CH3345/84A patent/CH661866A5/de not_active IP Right Cessation
- 1984-07-10 BE BE213306A patent/BE900125A/fr unknown
- 1984-07-10 CA CA000458551A patent/CA1238576A/fr not_active Expired
- 1984-07-10 SE SE8403659A patent/SE464683B/sv not_active IP Right Cessation
- 1984-07-11 DE DE19843425466 patent/DE3425466A1/de not_active Withdrawn
- 1984-07-11 GB GB08417677A patent/GB2144417B/en not_active Expired
- 1984-07-11 US US06/629,678 patent/US4581348A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CH661866A5 (de) | 1987-08-31 |
GB2144417B (en) | 1986-10-22 |
IT1214843B (it) | 1990-01-18 |
FR2548900B1 (fr) | 1988-12-09 |
GB8417677D0 (en) | 1984-08-15 |
ATA220684A (de) | 1989-03-15 |
IT8467682A0 (it) | 1984-07-04 |
CA1238576A (fr) | 1988-06-28 |
SE8403659L (sv) | 1985-01-12 |
FR2548900A1 (fr) | 1985-01-18 |
GB2144417A (en) | 1985-03-06 |
SE8403659D0 (sv) | 1984-07-10 |
US4581348A (en) | 1986-04-08 |
SE464683B (sv) | 1991-06-03 |
HUT34122A (en) | 1985-02-28 |
AT389052B (de) | 1989-10-10 |
HU190597B (en) | 1986-09-29 |
DE3425466A1 (de) | 1985-01-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5116871A (en) | Fatty acid therapy and compositions for the treatment of myalgic encephalomyelitis | |
EP0222483B1 (fr) | Utilisation de l'acide gamma-linolénique et des composés apparentés pour l'obtention d'un médicament pour le traitement de l'endométriose | |
US4415554A (en) | Treatment for menstrual disorders | |
ATE522211T1 (de) | Stabilisierte fibrat-mikropartikel | |
EP0440308A1 (fr) | Composition pharmaceutique et diététique | |
HK1061357A1 (en) | Fibrate-statin combinations with reduced fed-fasted effects | |
US5580556A (en) | Pharmaceutical compositions containing interferons and fatty acids | |
Koup et al. | Interaction of chloramphenicol with phenytoin and phenobarbital; Case report | |
US4855136A (en) | Therapeutic composition and method | |
IT1187687B (it) | Composizioni farmaceutiche contenenti come principi attivi flavanolignani e fosfolipidi | |
BE900125A (fr) | Compositions pharmaceutiques synergiques. | |
Memon et al. | In vivo effects of interferon-alpha and interferon-gamma on lipolysis and ketogenesis | |
AU7438287A (en) | Omega-3 fatty acid aided reduction of cyclosporin mephrotoxicity | |
Morshed et al. | Kinetics of propylene glycol elimination and metabolism in rat | |
JPS5716818A (en) | Steroid fatty emulsion | |
FR2712809B1 (fr) | Nouvelle composition pharmaceutique destinée à la préparation d'une poudre stable contenant, à titre d'ingrédient actif, une association d'acide acétylsalicylique et de métoclopramide. | |
DE3750426D1 (de) | Mittel zur Verbesserung spezifischer Eigenschaften des Blutes. | |
EP0211502B1 (fr) | Utilisation des métabolites de l'acide linoléique ou linolénique pour le traitement du syndrome prémenstruel | |
ATE285782T1 (de) | Pharmazeutische zusammensetzungen die ein alkylaryl polyether alkohol polymer enthalten | |
BE1002255A5 (fr) | Medicaments. | |
EP0087863A2 (fr) | Composition pharmaceutique et diététique | |
EP1148882B1 (fr) | Utilisation d'un agent reduisant la teneur en homocysteine dans le plasma pour la reduction du risque d'effets secondaires thromboemboliques induits par les hormones gestagenes | |
Cattaneo et al. | Effect of oral aspirin on plasma levels of vitamin K-dependent clotting factors–studies in healthy volunteers | |
Carlson et al. | A comparison of tryptophan pyrrolase adaptation in cattle, sheep, and rats | |
ES8400873A1 (es) | Procedimiento para preparar citidindifosfocolina para su administracion por via oral. |